Search
for

    Glossary Everolimus

    medication that inhibits mTOR pathway, used in cancer treatment

    Everolimus is a medication that inhibits the mTOR (mammalian target of rapamycin) pathway, which is crucial for cell growth and proliferation. It is commonly used in cancer treatment to slow tumor growth and in organ transplantation to prevent rejection. Additionally, it has applications in treating certain rare diseases and conditions like tuberous sclerosis complex.

    Research 5 of 100

    1. Gingival Hyperplasia Secondary to Everolimus Therapy Actas Dermo-Sifiliográficas · 2010
    2. Cutaneous Toxicities From Transplantation-Related Medications American Journal of Transplantation · 2017 · 14 citations
    3. ТУБЕРОЗНЫЙ СКЛЕРОЗ (БУРНЕВИЛЛЯ-ПРИНГЛА). ОБЗОР ЛИТЕРАТУРЫ 2026
    4. Virilizing insulinoma Endokrynologia Polska · 2025
    5. TRAPPED IN THE HYPOGLYCEMIA LOOP Journal of the ASEAN Federation of Endocrine Societies · 2025
    All research results →

    Learn

    — no results

    Try a deeper search in learn →

    Community

    — no results

    Try a deeper search in community →